GGrantIndex
Sort

51,593 grants matching hepatitis

Macrophage Functional Response in Hemolytic Complications

$490,524
Francesca Vinchi · New York Blood Center · P01 · FY2021 · HL

Macrophage Functional Response in Hemolytic Complications

$490,524
Francesca Vinchi · New York Blood Center · P01 · FY2023 · HL

Macrophage Functional Response in Hemolytic Complications

$490,524
Francesca Vinchi · New York Blood Center · P01 · FY2020 · HL

Methadone Patient Access to Collaborative Treatment (MPACT)

$490,522
Beth Meyerson · University Of Arizona · R61 · FY2023 · DA

Understanding mechanisms of liver carcinogenesis following developmental BPA exposure

$490,521
Caren Weinhouse · Oregon Health & Science University · R01 · FY2024 · ES

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C

$490,493
Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK

Splanchno-Hormonal Mechanisms of Cystic Fibrosis Related Diabetes

$490,492
Andrew W. Norris · University Of Iowa · R01 · FY2019 · DK

Splanchno-Hormonal Mechanisms of Cystic Fibrosis Related Diabetes

$490,492
Andrew W. Norris · University Of Iowa · R01 · FY2018 · DK

ONTOGENY OF HEPATIC ION TRANSPORT

$490,445
Frederick J Suchy · Icahn School Of Medicine At Mount Sinai · R37 · FY2007 · HD

Tissue-specific pathways of copper homeostasis in growth and development

$490,434
Michael J Petris · University Of Missouri-Columbia · R01 · FY2011 · DK

The role of cancer stem cells in liver cancer heterogeneity and subtypes

$490,425
Xin Wang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$490,425
Xin Wei Wang · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Host-microbiome interactions shape the metabolic effects of ketogenic diets

$490,405
Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2024 · DK

Molecular Prognostic Indicators in Liver Cirrhosis and Cancer

$490,399
Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · DK

CORTICOSEROID PHARMACOKINETICS AND PHARMACODYNAMICS

$490,379
State University Of New York At Buffalo · R01 · FY2004 · GM

Role of the innate immune defenses in viral infections

$490,363
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

MR Spectroscopy to Evaluate Liver Repopulation by Transplanted Hepatocytes

$490,349
Chandan Guha · Albert Einstein College Of Medicine · R33 · FY2010 · CA

Intestinal Barrier, Probiotic Bacteria, and the Gut-Liver Axis

$490,284
Thomas Y Ma · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · DK

Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion

$490,258
Gregory A Graf · University Of Kentucky · R01 · FY2023 · DK

Biomarkers of Metabolic and Vascular Risk in Obesity

$490,199
Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2009 · DK

Role of lncRNA Meg3 in obesity-induced endothelial senescence and insulin resistance

$490,183
Xinghui Sun · University Of Nebraska Lincoln · R01 · FY2022 · HL

Identification of metabolic regulators of glycerolipid synthesis and storage

$490,172
Kivanc Birsoy · Rockefeller University · R01 · FY2022 · DK

Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease

$490,162
Carol A Casey · University Of Nebraska Medical Center · R01 · FY2015 · AA

Behavioral Drug and HIV Risk Reduction Counseling with MMT in China

$490,156
Marek C Chawarski · Yale University · R01 · FY2015 · DA

Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis

$490,061
Anna Mae Elizabeth Diehl · Duke University · U01 · FY2022 · DK